Sympathetic neurons from perinatal rat pups extend only a single axon when maintained in culture in the absence of glia and serum. Exposure to recombinant osteogenic protein-1 (OP-1) selectively induces the formation of dendrites that correctly segregate and modify cytoskeletal and membrane proteins and form synaptic contacts of appropriate polarity. OP-1 requires nerve growth factor (NGF) as a cofactor, and, in the presence of optimal concentrations of NGF, OP-1-induced dendritic growth from cultured perinatal neurons is comparable to that observed in situ. Sympathetic neuroblasts that had not formed dendrites in situ also responded to OP-1 in culture, indicating that OP-1 can cause de novo formation as well as regeneration of dendrites. These data imply that specific signals can regulate the development of neuronal shape and polarity.
Introduction
Dendrites are the primary site of synapse formation in the vertebrate nervous system, and neurons that lack dendrites typically receive fewer synaptic inputs than cells with complex dendritic arbors (Purves, 1988) . Therefore, to understand how the number of afferent synapses is determined, it is necessary to identify the molecules that regulate the growth of dendrites.
Dendritic growth can be considered to occur in two phases: initial extension followed by elongation and ramification. Many molecules, including neurotransmitters, hormones, and neurotrophic factors, have been shown to modulate the expansion of the dendritic arbor (Kelly, 1988; Mattson, 1988; Snider, 1988) . Less is known about the factors that cause a neuron initially to form dendrites. Hippocampal neurons generate substantial dendritic arbors when they are cultured in the absence of their targets, of normal afferent input, and of contact with either glia or other hippocampal neurons (Dotti et al., 1988) . These data suggest that, in certain classes of neurons, initial dendritic sprouting occurs as part of an intrinsic developmental program and that execution of this program is relatively independent of trophic interactions. However, the initial stages of dendritic growth appear to be regulated differently in other classes of neurons. For example, rat sympathetic neurons fail to form dendrites and extend only axons when they are cultured in the absence of nonneuronal cells. In contrast, coculture with Schwann cells or astrocytes causes these neurons also to form dendritic processes and eventually to generate an arbor that is comparable in size to that observed in situ (Tropea et al., 1988; Johnson et al., 1989) . Since this change in cell shape is not observed with fibroblasts or heart cells, it would appear that specific trophic interactions are required to allow sympathetic neurons to form dendrites.
Trophic regulation of the initial stages of de ndritic growth has also been observed in cultures of mesencephalic, striatal, cerebral cortical, and preganglionic sympathetic neurons (Denis-Donini et al., 1984; Chamak et al., 1987; Clendening and Hume, 1990; Le Roux and Reh, 1994) , suggesting that it may be a fairly common mechanism for determining neuronal shape. However, little is known about the molecules that cause neurons to form dendrites. Indeed, the only trophic factor that has been clearly implicated in the regulation of the initial stages of dendritic growth is nerve growth factor (NGF). This growth factor causes a subpopulation of nodose neurons to form dendrites in culture (de Koninck et al., 1993) . Because these neurons lack dendrites in situ, the physiological significance of this effect is unclear. The observation is, however, consistent with the idea that there are trophic interactions that cause cells to form dendrites. NGF also enhances dendritic growth in sympathetic neurons when injected in situ (Snider, 1988) . However, by itself, NGF does not support dendritic growth in cultures of sympathetic neurons (Bruckenstein and Higgins, 1988) . It would therefore appear that there must be other molecules that regulate the morphological development of neurons.
OP-1, which is also known as bone morphogenetic protein-7 (BMP-7), is a member of the BMP/OP subfamily of the transforming growth factor I~ (TGFI3) superfamily (Sampath et al., 1992; Sampath and Rueger, 1994) . Other members of this family include OP-2 (Ozkaynak et al., 1992) and BMP-2 through BMP-6 (Wozney, 1993) . Many of these proteins were discovered using assays that measured de novo bone growth in vivo. However, there are indications that members of this subfamily also play a role in neural development. For example, mRNAs for OP-1, BMP-2, BMP-3, BMP-4, and BMP-5 have been detected in at least one region of the brain (Jones et al., 1991; Ozkaynak et al., 1992; Wozney, 1993) , and immunocytochemical studies indicate that BMP-6 is prominently expressed in most structures of the embryonic peripheral nervous system (Wall et al., 1993) . Other studies indicate that OP-1 increases expression of the adrenergic phenotype in neural crest cells (Varley et al., 1995) and regulates expression of L1 and neural cell adhesion molecule in a neural cell line (Perides et al., 1993) , whereas BMP-2 and BMP-6 affect the neurotransmitter phenotype of sympathetic neurons (Fann and Patterson, 1994) . Moreover, a recently discovered member of the BMP/OP subfamily, dorsalin, was cloned from a spinal cord cDNA library and subsequently found to affect the differentiation of both neural crest cells and motor neurons (Basler et al., 1993) .
This study examines the effects of OP-1 on perinatal rat sympathetic neurons. Our data indicate that OP-1 specifically induces dendritic growth in these cells, that it requires NGF as a cofactor, and that simultaneous exposure to both of these trophic factors causes the rate of expansion of the dendritic arbor in vitro to exceed that normally observed in situ. These observations suggest that, in addition to known trophic interactions that affect the survival and neurotransmitter phenotype of sympathetic neurons (Thoenen and Barde, 1980; Patterson and Landis, 1992) , there may be others that specifically regulate their morphological development.
Results

OP-1 Induces Dendritic Growth in Sympathetic Neurons
Sympathetic neurons were dissociated from the superior cervical ganglia of perinatal rats. They were then plated onto polylysine-coated coverslips and maintained in a serum-free medium that contained NGF. Nonneuronal cells were eliminated by treatment with an antimitotic agent on days 2 and 3. One to 2 days were then allowed for recovery before beginning experimental treatments on day 5 or 6. Cellular morphology was initially assessed by intracellular dye injection.
Under control conditions, sympathetic neurons typically extend a single process during the first 24-48 hr in vitro. Previous studies have shown that this process has the cytoskeletal and ultrastructural characteristics of an axon (Tropea et al., 1988; Lein and Higgins, 1989) . The axon continues to elongate during the next few weeks and generates an elaborate plexus ( Figure 1) . However, the basic morphology of the cells remains essentially unchanged (Figure 2) , with 80% of the neurons still being unipolar after 1 month. Most of the remaining population had either 2 axons (13% of the cells) or an axon and a short dendrite (7%). Thus, the mean number of processes at this time was 1.13 + 0.06 (n = 30)axons/cell and 0.07 _ 0.04 dendrites/cell.
Exposure to recombinant human OP-1 caused sympathetic neurons to form additional processes (see Figure  1 ). The response was relatively slow, with only 42% of the cells forming a second process within 24 hr (see Figure  2) . However, virtually all cells responded to maximally effective concentrations within 3 days. The processes that Figure 1 . Effects of OP-1 on the Morphological Development of Sympathetic Neurons Phase-contrast (A and C) and fluorescence (B and D) micrographs of neurons injected with Lucifer yellow during the third week in vitro. Neurons in control cultures (A and B) typically had only 1 process, a long axon. Neurons exposed to OP-1 (C and D) were multipolar, having several tapered dendrites and 1 axon. There was a tendency for the axons of OP-l-treated neurons to form small fascicles on polylysine. However, this was not observed on other substrates, such as laminin, which also supported OP-l-induced dendritic growth, suggesting that it is an epiphenomenon unrelated to the growth of dendrites. Bar, 50 t~m. formed in the presence of OP-1 had the appearance of dendrites in that they were broad-based (up to 5 I~m in diameter), exhibited a distinct taper, and branched in a "Y"-shaped pattern, with daughter processes being significantly smaller than the parent process (see Figure 1 ). Dendrites were much thicker than axons, and unlike axons, they ended locally, usually extending less than 300 ~m from the soma. The number of dendrites per cell continued to increase during a 4 week exposure to OP-1, with most of the change occurring during the first 10 days of treatment (see Figure 2 ). After 4 weeks, OP-l-treated neurons had a mean of 7.3 _ 0.3 (n = 30) dendrites/cell, representing an increase of -100-fold over control cells. Exposure to OP-1 did not cause an increase in the number of axons per cell when it was tested in the delayed introduction paradigm used in the experiment shown in Figure 2 . We also examined the effects of OP-1 on initial axon growth during the first 48 hr in culture. Neither the rate at which axons were initially extended nor the mean number of axons per cell was affected (data not shown). It therefore appears that OP-1 affects sympathetic neurons in a process-specific manner.
Cell number also remained constant during the exposure to OP-1 (see Figure 2 ), indicating that it was not acting by enhancing the survival of a subpopulation of neurons. However, the somata of neurons treated with OP-1 were larger than those of control cells (see Figure 1 ). The significance of this change is unclear, but since somatic hypertrophy is also associated with sympathetic dendritic growth in situ (Voyvodic, 1987) , it could simply reflect the added synthetic capacity needed to sustain the growth of additional processes.
Properties of Dendrites Formed in the Presence of OP-1
When cultures exposed to OP-1 were immunostained with a monoclonal antibody (MAb) to microtubule-associated protein-2 (MAP2), immunoreactMty was observed in the somata and dendritic processes, but not in the thinner axons ( Figure 3) . Moreover, the mean number and average length of the MAP2-positive processes corresponded closely (within 10%) to the values obtained from dye injections, suggesting that all dendrites were stained in their entirety. A similar staining pattern was observed with MAbs to nonphosphorylated neurofilaments ( Figure 3 ) and to the transferrin receptor (data not shown). In contrast, MAbs to tau (Figure 3) , synaptophysin, or phosphorylated forms of the H or the M and H neurofilament subunits (data not shown) selectively stained the thin axons, with little or no immunoreactivity observed in the dendrites.
When cultures treated with OP-1 were examined in the electron microscope, tapered dendrites were frequently observed emanating from neural somata. The dendritic cytoplasm was continuous with that of the soma, and proximal dendrites contained both polyribosomes and occasional short segments of rough endoplasmic reticulum. Polyribosomes were also observed in more distal dendrites at distances greater than 100 p.m from the soma but were not observed in axons. In contrast, synaptic vesicles were seen only in axons. Dendrites were typically smoothly contoured and lacked the spinelike protrusions observed on some sympathetic neurons in situ (Matthews, 1983) . However, the synaptic contacts that were found along dendrites had an appropriate polarity; both presynaptic axonal accumulations of vesicles and postsynaptic densities were observed.
Concentration-Effect Relationship and Comparison of OP-1 with Other Growth Factors
The effects of OP-1 were concentration dependent ( Figure  4A ). Maximal dendritic growth was obtained with concentrations between 30 and 100 ng/ml, and half-maximal effects were observed at -2 ng/ml. However, significant changes in dendritic growth could be detected with concentrations as low as 300 pg/ml. These data suggested Phase-contrast (A) and fluorescence (B) micrographs of a neuron that was exposed to OP-1 for 18 days before being immunostained with a MAb (AP13) to MAP2. Immunoreactivity was observed primarily in the soma and dendrites, although there was occasional labeling of an axon (B, lower right). A similar staining pattern (C) was observed in cultures reacted with a MAb (SMI-32) to nonphosphorylated forms of the M and H neurofilament subunits (21 day exposure to OP-1). In contrast, prominent axonal labeling was observed in cultures reacted with a MAb to tau protein (D); an enlargement is shown in (E). Label was also observed in the region of the cell body and dendrites, but confocal microscopy (1 ~m optical sections) revealed that it was primarily associated with axons coursing over the surface of these structures (E). Bars, 50 ~m (B and C). a specific effect of the recombinant protein upon neurons, and this was confirmed by antibody blocking experiments. MAbs 1B12 and 12G3 have previously been shown (Vukicevic et al., 1994) to react with OP-1 but not with closely related molecules, such as BMP-2 and BMP-4. When added to the medium at a concentration of 5 ~g/ml, MAbs 1 B12 and 12G3 inhibited OP-l-induced (2 ng/ml) dendritic growth by 71% and 100%, respectively.
Since OP-1 belongs to the TGF~ superfamily, its actions were compared with those of other family members. Dendritic growth was not observed in the presence of TGF~I, TGFI32, TGFI~3, activin A, inhibin, or gila-derived neurotrophic factor (all tested at 100 ng/mi). Negative results were also obtained with similar concentrations of members of the neurotrophin (NT) family (NT3, NT4, and brainderived neurotrophic factor), basic fibroblast growth factor, epidermal growth factor, ciliary neurotrophic factor, leukemia inhibitory factor, hepatocyte growth factor, granulocyte/macrophage colony-stimulating factor, F interferon, platelet-derived growth factor, TGFc~, vascular endothelial growth factor, and interleukin-113, -2, -3, -4, -6, -7, and -8. These data suggest that the dendrite-promoting effect of OP-1 is a specific response that is not observed with most of the other growth factors known to affect neurons.
Effects of NGF on OP-l-lnduced Dendritic Growth
NGF regulates the growth of sympathetic dendrites in situ (Snider, 1988) , but dendritic growth was not observed in our control medium, which contained high levels of NGF. We therefore considered the hypothesis that NGF functions as a modulator rather than an inducer of dendritic growth. Neurons were exposed to a maximally effective concentration of OP-1 while the amount of NGF was varied. As the concentration of NGF was decreased from 100 to 0.3 ng/ml ( Figure 4B than 2-fold from that for either the percentage of cells with dendrites or the number of dendrites. These data suggest that NGF is a necessary cofactor for OP-l-induced dendritic growth and that the amount of dendritic growth that occurs is critically dependent on the trophic state of the cell. A separate experiment directly examined the acute effects of OP-1 on neuronal survival in the presence and absence of NGF. In control medium containing NGF (100 ng/ml), 63% of the neurons plated survived for 48 hr under our low density culture conditions (9455 _+ 445 neurons/ 22 mm well). A similar number (9641 _ 686 neurons/well) survived in the presence of both NGF and OP-1 (50 ng/ ml). In the absence of NGF, few neurons (62 _+ 25 neurons/well) survived, and this number was not signficantly increased in the presence of OP-1 (93 ± 74 neurons/well). Similar results were obtained with cultures of neurons from 2-day-old pups (data not shown). In addition, OP-1 did not potentiate the effects of submaximal concentrations (0.1-30 ng/ml) of NGF on survival. Thus, the effects of OP-1 are distinct from those of NGF, in that the former does not support neuronal survival.
Comparison of Dendritic Growth In Vitro and In Situ
To assess the potential importance of OP-1 as a regulatory molecule, we compared the amount of dendritic growth that occurs in vitro with that which normally occurs during a comparable period in situ (Table 1) . For the former, we used cultures that had been exposed to optimal concentrations of OP-1 and NGF for 2 weeks. For the latter, we used published data (Snider, 1988) describing the dendritic morphology of superior cervical ganglion neurons in 2-weekold rat pups. Cells exposed to OP-1 in vitro were at least as complex as their counterparts in situ. They had about the same number of dendrites as cells in situ, but the length of their dendritic arbor was 38% greater. The increase in the size of the dendritic arbor in vitro seemed to be due primarily to increases in the radial length of dendrites because there was no detectable change in the amount of branching, as assessed by the method of Scholl (1953) . Since these experiments were performed in a serum-free medium, it appears that a combination of only two trophic factors is a sufficient stimulus to allow the establishment of a dendritic arbor of approximately normal dimensions.
OP-1 Induces Dendritic Growth in Naive Neurons
Many sympathetic neurons have formed rudimentary dendrites by the time of birth. Therefore, the previous experiments primarily reflect effects of OP-1 on dendritic regeneration. To determine whether OP-1 could also promote de novo formation of these processes, we tested its effects on sympathetic neurons taken from 14.5 day embryos. At this time, there are still many neuroblasts in sympathetic ganglia (Hendry, 1977) .
Approximately half of the neurons from control and OP-1-treated cultures synthesized DNA (Table 2) . Only a small subpopulation of control neurons formed dendrites; in contrast, 95% of the neurons exposed to OP-1 formed such processes. Moreover, in OP-l-treated cultures, the number of dendrites per neuron was similar in thymidinelabeled and unlabeled cells, suggesting that primitive neurons just exiting the cell cycle respond to OP-1 about as well as more mature postmitotic neurons. OP-l-treated cultures from 14.5 day embryos were examined by immunocytochemistry, and the pattern of staining was essentially identical to that observed in cultures from perinatal animals: the dendrites were selectively labeled with MAbs to MAP2 and nonphosphorylated forms of the M and H neurofilament subunits, while axons reacted with antibodies to tau, synaptophysin, and phosphorylated forms of the M and H neurofilament subunits.
Discussion
Our data indicate that OP-1 induces the formation of dendrites in sympathetic neurons, and that in the presence of an optimal concentration of NGF, the dendritic arbor expands at a rate at least equivalent to that observed dur- 29.2 ± 6.0 32.9 ± 0.5
Cultures of sympathetic neurons were immunostained with MAb SMI-32 after a 2 week exposure to OP-1. Data are expressed as the mean ± SEM (n = 40). a In situ data are from Snider (1988) . Mean ± SD.
ing the first 2 postnatal weeks in situ. These observations suggest the existence of a novel type of trophic influence upon sympathetic neurons: one that affects cell shape without affecting survival. Some neural crest derivatives, such as sensory and many parasympathetic neurons, form only axons, whereas others, such as sympathetic neurons, also extend dendrites. The mechanisms that cause sympathetic neurons to diverge in shape have remained obscure. Our data indicate that sympathetic neurons form only axons when they are maintained in the presence of their target-derived survival factor, NGF. Since cells grown under these conditions have previously been shown to have many properties expected of sympathetic neurons, such as appropriate electrical properties, receptors, and neurotransmitter phenotype , it appears that the extension of dendrites is not a constitutive part of the program for sympathetic differentiation. Rather, it seems to be a subroutine whose expression is differentially regulated. In this respect, it is interesting to note that there has been an evolutionary change in the morphology of sympathetic neurons: amphibian sympathetic neurons are typically unipolar while their mammalian counterparts usually have dendrites (Elfvin, 1983) .
Previous studies of sympathetic neurons suggested that the growth requirements of dendrites are more demanding than those of axons, with the former requiring molecules derived from sera, glia, or basement membranes (Tropea et al., 1988; Lein and Higgins, 1989) . However, the poorly defined nature of these stimuli made it difficult to distinguish specific effects on dendrites from nonspecific Sympathetic ganglia from 14.5 day embryos were labeled for 18 hr with [3H]thymidine and then dissociated. After nonneuronal cells had been eliminated, some cultures were treated with OP-1 (100 ng/ml) for 12 days. Cultures were then immunostained with MAb SMI-32 and processed for autoradiography. Data are expressed as mean _+ SEM (n i> 100).
changes in the health of neurons. The current data indicate that exposure to a recombinant growth factor induces dendritic growth, and that this effect is blocked by MAbs that react with OP-1 but not with other closely related BMPs. The effects of OP-1 were observed in cultures grown in the absence of nonneuronal cells, indicating a direct effect upon neurons. Moreover, the structural requirements for inducing dendritic growth are quite stringent since this effect was not observed with 26 other growth factors, including members of the TGFI3 family. These observations strongly suggest that specific trophic interactions can regulate the development of neuronal cell shape. Most of the sympathetic neurons that were obtained from perinatal pups had established rudimentary dendritic arbors in situ (Voyvodic, 1987) . In contrast, -50% of the neurons taken from 14.5 day embryos were still synthesizing DNA, and the others had just reached the stage where they were beginning to form dendrites in situ (Rubin, 1985) . Yet virtually all of the neurons from these two groups formed dendrites in the presence of OP-I. These data suggest a potential morphogenetic role for OP-1 since it not only sustains dendritic regeneration but also promotes de novo synthesis in naive neurons.
The dendrites formed in the presence of OP-1 were appropriate to sympathetic neurons in their shape, length, and number. They also exhibited appropriate functional specializations (Craig and Banker, 1994) . Thus, these dendrites accumulate and postranslationally modify selected cytoskeletal and membrane proteins; exclude axonal proteins, transport ribosomes, and other types of RNA (unpublished observations, P. L. and D. H.); and form synaptic contacts of correct polarity. The simplest explanation for these phenomena is that OP-1 induces the execution of a cellular program that controls both quantitative and qualitative aspects of dendritic growth. Consistent with the notion of a program is the recent finding that nodose neurons, which normally do not form dendrites in situ, appropriately segregate cytoskeletal proteins when dendritic growth is induced in vitro (de Koninck et al., 1993) . However, if this is the case, it is important to note that this does not appear to be an unrestricted program for dendritic growth, because we never saw sympathetic cells with dendritic arbors that resembled those of pyramidal or Purkinje cells or with well-developed dendritic spines.
NGF regulates dendritic development in sympathetic neurons in situ (Snider, 1988; Ruit et al., 1990) . A similar NGF dependence was noted in this study. In fact, in the presence of optimal concentrations of NGF and OP-1, a dendritic arbor of normal dimensions was formed. Since our experiments were not performed at clonal density, one cannot rule out the involvement of intimate cell-cell interactions, such as those mediated by cell adhesion molecules, in the development of dendrites in vitro. However, since the neurons were grown at low density in the absence of nonneuronal cells, the data suggest that the number of trophic substances that would have to be provided by other cell types, including targets, gila, and preganglionic fibers, is quite limited and that it could potentially consist of only two molecules.
The relevance of this model to the regulation of dendritic growth in situ is still unclear. However, OP-1 mRNA or protein has been detected in most adult rat tissues that receive a sympathetic innervation, with particularly high levels being found in the kidney and in association with basement membranes (Ozkaynak et at., 1992; Wozney, 1993; Vukicevic et al., 1994) . OP-1 might therefore function as a target-derived factor. Alternatively, the situation may be more complex, with local sources of dendritepromoting molecules also being involved. OP-1 and BMP-6 are closely related homologs with greater than 90% amino acid identity in the cysteine portion of the mature protein. Wall et al. (1993) found that BMP-6 is present in high concentration in most parts of the embryonic peripheral nervous system. In addition, Schluesener et al. (1995) have reported that adult rat Schwann cells express BMP-6, and our preliminary data suggest that their embryonic counterparts synthesize OP-1 (P. L. and D. H.). Thus, although the current data are limited, they suggest that sympathetic neurons may be exposed to dendritepromoting BMPs both during development and in adulthood.
Trophic factors can affect many aspects of the development of sympathetic neurons, including their survival, rates of axonal growth, and neurotransmitter phenotype (Patterson and Nawa, 1993) . The actions of OP-1 are distinct from those of NGF (Thoenen and Barde, 1980) and NT3 (Birren et al., 1993) because OP-1 does not support neuronal survival. The effects of OP-1 are also different from those of extracellular matrix molecules such as laminin and collagen IV, which selectively promote axonal elongation (Lein and Higgins, 1989; Lein et al., 1991) and which, in some cases, can also cause the formation of multiple axons. In contrast, OP-1 did not have detectable effects on either the initial extension of axons or the number of axons per cell in long-term culture. The relationship between the regulation of neurotransmitter phenotype and morphological development is less clear. Molecules such as cholinergic differentiation factor/leukemia inhibitory factor and ciliary neurot:ophic factor, which induce cholinergic function in sympathetic neurons (Patterson and Landis, 1992) , failed to promote dendritic growth, suggesting these developmental processes can be regulated independently. On the other hand, the recent finding that BMP-2 and BMP-6 cause sympathetic neurons to express unique profiles of mRNAs for neuropeptides (Fann and Patterson, 1994) indicates that there could also be some overlap between the regulation of cell shape and neurotransmitter phenotype. In either case, the data are consistent with a model in which multiple trophic interactions govern the expression of the complex assemblage of traits that comprise the sympathetic neuronal phenotype (Patterson and Nawa, 1993) . The data also indicate that members of the BMP/OP family can exert profound and unique effects on the development of autonomic neurons. Such actions are consistent with their well-established role as differentiation factors in other systems, especially mesenchymal tissues (Wozney, 1993) .
Experimental Procedures Materials
Mature human recombinant OP-1 was isolated from medium conditioned by transfected Chinese hamster ovary cells using S-Sepharose and phenyI-Sepharose chromatography followed by reverse phase high performance liquid chromatography (Sampath et al., 1992) . The purity was >98%, as assessed by SDS-polyacrylamide gel electrophoresis. Other growth factors were obtained from commercial sources: GIBCO/BRL (interleukin-t J~, -3, -4, -6, and -7; epidermal growth factor, basic fibroblast growth factor, granulocyte/macrophage colonystimulating factor, leukemia inhibitory factor, TGFa, and rat F interferon); PeproTech, inc. (brain-derived neurotrophic factor, NT3, NT4, ciliary neurotrophic factor, and glial-derived neurotrophic factor); R&D Systems (-IGF~I, TGFI~2, TGF~3, and vascular endothelial growth factor); Collaborative Biomedical Products (hepatocyte growth factor, platelet-derived growth factor, and TGF~); Boehringer Mannheim (interleukin-2); and Promega (interleukin-8). MAbs (1B12 and 12G3; Creative Biomolecules, Inc.) that react with OP-1, but not with BMP-2 or BMP-4, were affinity purified with Protein A agarose (Vukicevic et al., 1994) .
Tissue Culture
Suspensions of neurons dissociated from the superior cervical ganglia of Holtzman (Harlan Sprague-Dawley) rat fetuses (20-21 days) or rat pups (1-3 days postnatal) were prepared according to the method of Higgins et al. (1991) . Equivalent results were obtained with pre~ and postnatal animals. Neurons were plated at low density (-10 cells/ mm 2) onto poly-D-lysine-coated (100 ilg/ml) coverslips and maintained in a serum-free medium containing 13-NGF (100 ng/ml) and three other proteins: bovine serum albumin (500 p.g/ml), bovine insulin (10 p.g/ml), and human transferrin (10 pg/ml). Equivalent results were obtained with NGF purified from mouse salivary glands (gift from E. M. Johnson) and recombinant human NGF (PeproTech, Inc.). Cytosine-~-b-arabinofuranoside (1 ~.M) was added to the medium of all cultures for 48 hr beginning on the second day; this exposure was usually sufficient to render them virtually free of nonneuronal cells for 30 days.
To label sympathetic neuroblasts, ganglia from 14.5 day rat embryos were grown in explant culture for 18 hr in the presence of [methyl-3H]thymidine (0.3 p.Ci/ml; ICN Biomedicals, Inc.). Subsequently, the ganglia were exposed to trypsin, and the dissociated cells were plated on laminin-coated (10 ~.g/ml) coverslips . Because NT3 (50 ng/ml) enhances the survival of immature sympathetic neurons (Birren et al., 1993) , it was added to the NGF-containing medium during the period of explant culture and during the first 4 days of dissociated cell culture.
Morphological Analyses
Cellular morphology was routinely assessed by the intraceUular injection of fluorescent dyes, Lucifer yellow (4%) or 5(6) carboxyfl uorescein (5%). Only neurons whose cell bodies were at least 150 ~m from other neuronal somata were injected because density-dependent changes in morphology occur when sympathetic neurons are separated by lesser distances (Bruckenstein and Higgins, 1988) .
Cultures were immunostained with antibodies previously shown to react selectively with either axons or dendrites (Sternberger and Ster-nberger, 1983; Wiedenmann and Franke, 1985; Binder et al., 1986; Lein and Higgins, 1989; Cameron et al., 1991) . MAbs to MAP2 (AP13 and AP14; gift of L. I. Binder), to nonphosphorylated forms of the M and H neurofilament subunits (SMI-32; Sternberger-Meyer Immunocytochemicals), and to the transferrin receptor (MRC OX-26; Serotech) were used as dendritic markers. Axonal probes included MAbs to synaptophysin (SY-38; Boehringer Mannheim), tau (Taul; L. I. Binder), and phosphorylated forms of the H (NE14; Boehringer Mannheim) and the M and H (SMI-31 ; Sternberger-Meyer Immunocytochemicals) neurofilament subunits. All antigens were localized by indirect immunofluorescence using previously described procedures (Lein and Higgins, 1989) . Image 1 Software (Universal Imaging) was used to quantitate dendritic growth in immunostained cultures. Maximum dendritic extent was determined by measuring the radius of a circle encompassing the entire arbor. The number of branches crossing a circle of half that diameter was used as an index of branching (Schotl, 1953) . Cultures were prepared for electron microscopy according to published procedures (Tropea et al., 1988) . Data in the text are presented as mean -SEM.
